Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sphingosine 1-phosphate as a therapeutic agent.

S Spiegel1, R Kolesnick

  • 1Department of Biochemistry, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298-0614, USA.

Leukemia
|August 30, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S1P lyase inhibition prevents lung injury following high pressure-controlled mechanical ventilation in aging mice.

Experimental gerontology·2022
Same author

T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage.

Science immunology·2019
Same author

NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress.

Nature communications·2019
Same author

Correction: S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells.

Leukemia·2019
Same author

Detection and Partial Molecular Characterization of Two Plum pox virus Isolates from Plum and Wild Apricot in Southeast Kazakhstan.

Plant disease·2019
Same author

Natural Infection of Verbena and Phlox by a Recently Described Member of the Carmovirus Genus.

Plant disease·2019

Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator with dual intracellular and extracellular functions. S1P therapy prevented radiation-induced oocyte loss, offering potential therapeutic applications for infertility.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite.
  • S1P acts as a ligand for five G protein-coupled receptors (GPCRs).
  • S1P has intracellular roles in calcium homeostasis, cell growth, and apoptosis suppression.

Purpose of the Study:

  • To explore the dual actions of S1P within and outside cells.
  • To investigate the role of S1P in regulating diverse cellular processes.
  • To assess the therapeutic potential of S1P in preventing oocyte loss.

Main Methods:

  • Activation of sphingosine kinase leads to S1P formation.
  • GPCR activation by S1P regulates cell migration, angiogenesis, and development.
  • In vivo therapy with S1P was used to evaluate its effects on radiation-induced oocyte loss.

Related Experiment Videos

Main Results:

  • S1P regulates cell migration, angiogenesis, vascular maturation, heart development, and neurite retraction.
  • Intracellular S1P levels, along with ceramide, determine cell fate.
  • In vivo S1P therapy completely prevented radiation-induced oocyte loss in mice.

Conclusions:

  • S1P is a critical lipid mediator with diverse regulatory functions.
  • S1P plays a significant role in cell fate determination and pathological conditions involving apoptosis.
  • S1P represents a promising therapeutic target for conditions like infertility and premature ovarian failure.